Latest Breaking News On - Alkermes board - Page 1 : comparemela.com

Alkermes plc: Independent Proxy Advisory Firm Glass Lewis Recommends Alkermes Shareholders Vote FOR All Seven of the Company's Highly Qualified Director Nominees

Independent Proxy Advisory Firm ISS Recommends Alkermes Shareholders Vote Against Sarissa Employees' Election to Alkermes Board

/PRNewswire/ Alkermes plc (Nasdaq: ALKS) (the Company) today announced that independent shareholder advisory firm Institutional Shareholder Services (ISS).

Hedge Fund and Insider Trading News: Ken Griffin, Crispin Odey, Joel Greenblatt, Ancora Advisors, Sarissa Capital, Elliott Management, Clene Inc. (CLNN), Asana, Inc. (ASAN), and More

Proxy advisory firm Institutional Investor Services urged Alkermes (ALKS.O) shareholders to elect one of three director candidates proposed by activist hedge fund Sarissa Capital, arguing more outside.

Alkermes To Spin-Off Mural Oncology In 2H23

ALKS, $31.48, Market Capitalization: $5.2 billion), a fully-integrated, global biopharmaceutical company developing innovative medicines in the fields of neuroscience .

Alkermes Issues Letter to Shareholders Highlighting Skills and Experience of Refreshed Board of Directors

/PRNewswire/ Alkermes plc (Nasdaq: ALKS) (the Company) today issued a letter to its shareholders in connection with the Company s upcoming 2023 Annual.